NOT-CA-17-048: Notice of Change to Key Dates in PAR-16-111 "Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)"

Notice of Change to Key Dates in PAR-16-111 "Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)"

Notice Number: NOT-CA-17-048

Key Dates
Release Date: April 10, 2017

Related Announcements
PAR-16-111

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to revise the Key Dates for PAR-16-111, "Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01)".

Part 1. Key Dates

Currently reads:

Application Due Date(s): July 14, 2016; December 14, 2016; July 14, 2017; December 14, 2017

Advisory Council Review: January 2017; August 2017; January 2018; August 2018

Earliest Start Date: April 2017; December 2017; April 2018; December 2018

Expiration Date: December 15, 2017

Modified to read:

Application Due Date(s): July 14, 2016; December 14, 2016; July 14, 2017; November 14, 2017

Advisory Council Review: January 2017; May 2017; January 2018; May 2018

Earliest Start Date: April 2017; July 2017; April 2018; July 2018

Expiration Date: November 15, 2017

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Eric Bernhard, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5704
Email: bernhardej@mail.nih.gov

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: ncirefof@dea.nci.nih.gov